SCHEMBL3340320

SCHEMBL3340320

Cc1ccc(-n2ccc(=O)[nH]c2=O)cc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 3/20 0.51
DDB1 Q16531 1/20 0.51
MAPT P10636 5/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HCAR1 Q9BXC0 1/20 0.40
ALDH1A1 P00352 5/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 2/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
CASP1 P29466 1/20 0.38
CYP3A4 P08684 2/20 0.36
ATAD2 Q6PL18 1/20 0.36
ATM Q13315 1/20 0.36
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23296161 0.87 CRBN (0.51) CRBNDDB1MAPTKDM4EHCAR1
SCHEMBL25565822 0.84 CRBN (0.56) CRBNDDB1MAPTMEN1KMT2A
SCHEMBL3346087 0.81 MAPT (0.47) MAPTKDM4EMEN1KMT2ANPSR1
SCHEMBL3340313 0.78 CRBN (0.46) CRBNDDB1MAPTMEN1KMT2A
SCHEMBL25553210 0.78 CRBN (0.49) CRBNDDB1MAPTHCAR1ALDH1A1
SCHEMBL1380327 0.77 CRBN (0.66) CRBNDDB1MAPTHCAR1ALDH1A1
SCHEMBL5325743 0.77 CRBN (0.66) CRBNDDB1MAPTKDM4EHCAR1
SCHEMBL15717334 0.77 SMN1; SMN2 (0.49) MAPTKDM4EMEN1KMT2ANPSR1
SCHEMBL23296165 0.77 CRBN (0.51) CRBNDDB1MAPTHCAR1ALDH1A1
SCHEMBL3343075 0.75 ATAD2 (0.46) MAPTKDM4EMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 CRBN 3855/4885DDB1 2476/4885MAPT 2598/4885
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 CRBN 3110/4885DDB1 1923/4885MAPT 4154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.